lobbying_activities: 2186753

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2186753	56db97d3-cddb-4921-946b-6c43e79a2049	Q3	TRAVERE THERAPEUTICS	401104190	TRAVERE THERAPEUTICS	2018	third_quarter	PHA	Orphan Drug Act, Drug Quality and Security Act drug safety issues, drug pricing, opioid legislation provisions related to opioid sparing, FAST Generics and CREATES Acts, FDA issues	HOUSE OF REPRESENTATIVES,SENATE		220000	0	0	2018-10-16T22:45:04.840000-04:00